Yatsuhashi H - Search Results

1

No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.

Korenaga M, Murata K, Izumi N, Tamaki N, Yokosuka O, Takehara T, Sakamoto N, Suda G, Nishiguchi S, Enomoto H, Ikeda F, Yanase M, Toyoda H, Genda T, Umemura T, Yatsuhashi H, Yamasaki K, Ide T, Toda N, Kanda T, Nirei K, Ueno Y, Haga H, Nishigaki Y, Nakane K, Omata M, Mochizuki H, Aoki Y, Imamura M, Kanto T, Mizokami M. Korenaga M, et al. Among authors: yatsuhashi h. Glob Health Med. 2022 Aug 31;4(4):216-224. doi: 10.35772/ghm.2022.01026. Glob Health Med. 2022. PMID: 36119787 Free PMC article.

2

Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon.

Yatsuhashi H, Yamasaki K, Aritomi T, Maria P, Carmen D, Inoue O, Koga M, Yano M. Yatsuhashi H, et al. J Gastroenterol Hepatol. 1997 Jun;12(6):460-7. doi: 10.1111/j.1440-1746.1997.tb00467.x. J Gastroenterol Hepatol. 1997. PMID: 9195405

3

Association of mutations in the core promoter and precore region of hepatitis virus with fulminant and severe acute hepatitis in Japan.

Aritomi T, Yatsuhashi H, Fujino T, Yamasaki K, Inoue O, Koga M, Kato Y, Yano M. Aritomi T, et al. Among authors: yatsuhashi h. J Gastroenterol Hepatol. 1998 Nov;13(11):1125-32. doi: 10.1111/j.1440-1746.1998.tb00588.x. J Gastroenterol Hepatol. 1998. PMID: 9870800

4

Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection.

Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, Yano M. Khan KN, et al. Among authors: yatsuhashi h. J Hepatol. 2000 Feb;32(2):269-78. doi: 10.1016/s0168-8278(00)80072-0. J Hepatol. 2000. PMID: 10707867

5

Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease.

Watanabe H, Nagayama K, Enomoto N, Chinzei R, Yamashiro T, Izumi N, Yatsuhashi H, Nakano T, Robertson BH, Nakasone H, Sakugawa H, Watanabe M. Watanabe H, et al. Among authors: yatsuhashi h. J Gen Virol. 2003 Dec;84(Pt 12):3275-3289. doi: 10.1099/vir.0.19499-0. J Gen Virol. 2003. PMID: 14645909

6

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.

Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H. Ikeda M, et al. Among authors: yatsuhashi h. J Gastroenterol. 2005 Feb;40(2):148-56. doi: 10.1007/s00535-004-1519-2. J Gastroenterol. 2005. PMID: 15770398

7

Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.

Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H. Ikeda M, et al. Among authors: yatsuhashi h. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):122-8. doi: 10.1111/j.1440-1746.2005.04083.x. J Gastroenterol Hepatol. 2006. PMID: 16706823

8

Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.

Sugauchi F, Orito E, Ohno T, Tanaka Y, Ozasa A, Kang JH, Toyoda J, Kuramitsu T, Suzuki K, Tanaka E, Akahane Y, Ichida T, Izumi N, Inoue K, Hoshino H, Iino S, Yotsuyanagi H, Kakumu S, Tomita E, Okanoue T, Nishiguchi S, Murawaki Y, Hino K, Onji M, Yatsuhashi H, Sata M, Miyakawa Y, Ueda R, Mizokami M. Sugauchi F, et al. Among authors: yatsuhashi h. Hepatol Res. 2006 Oct;36(2):107-14. doi: 10.1016/j.hepres.2006.06.001. Epub 2006 Sep 7. Hepatol Res. 2006. PMID: 16956789

9

Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.

Shinkai N, Tanaka Y, Ito K, Mukaide M, Hasegawa I, Asahina Y, Izumi N, Yatsuhashi H, Orito E, Joh T, Mizokami M. Shinkai N, et al. Among authors: yatsuhashi h. J Clin Microbiol. 2007 Oct;45(10):3191-7. doi: 10.1128/JCM.00411-07. Epub 2007 Jul 25. J Clin Microbiol. 2007. PMID: 17652471 Free PMC article.

10

Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan.

Umemura T, Tanaka E, Kiyosawa K, Kumada H; Japan de novo Hepatitis B Research Group. Umemura T, et al. Clin Infect Dis. 2008 Sep 1;47(5):e52-6. doi: 10.1086/590968. Clin Infect Dis. 2008. PMID: 18643758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page